We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+3.62%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
AUM
$339M
AUM Growth
-$165M
Cap. Flow
-$180M
Cap. Flow %
-53.14%
Top 10 Hldgs %
33.61%
Holding
51
New
5
Increased
1
Reduced
30
Closed
5

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$17.9M
2
MDLZ icon
Mondelez International
MDLZ
+$17.6M
3
LOW icon
Lowe's Companies
LOW
+$17.2M
4
PPL
PPL Corp
PPL
+$14.5M
5
PM icon
Philip Morris
PM
+$13M

Sector Composition

Rank Sector Weight
1 Healthcare 30.07%
2 Technology 12.94%
3 Financials 11.14%
4 Communication Services 9.58%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOG icon
26
EOG Resources
EOG
$75.1B
$8.78M 2.59%
70,520
-36,460
-34% -$4.24M
TMO icon
27
Thermo Fisher Scientific
TMO
$223B
$8.45M 2.49%
40,810
-25,000
-38% -$5.31M
BNY
28
Bank of New York Mellon
BNY
$111B
$7.83M 2.31%
145,270
+131,970
+992% +$7.28M
JNJ icon
29
Johnson & Johnson
JNJ
$629B
$7.76M 2.29%
63,965
-30,360
-32% -$3.79M
KMI icon
30
Kinder Morgan
KMI
$70.7B
$7.55M 2.23%
427,415
-167,550
-28% -$2.74M
CVX icon
31
Chevron
CVX
$386B
$7.5M 2.21%
59,325
-29,060
-33% -$3.61M
CB icon
32
Chubb
CB
$132B
$7.42M 2.19%
58,455
-17,740
-23% -$2.36M
CELG
33
DELISTED
Celgene Corp
CELG
$7.33M 2.16%
92,318
-34,065
-27% -$2.83M
FE icon
34
FirstEnergy
FE
$27.2B
$1.04M 0.31%
28,900
ADP icon
35
Automatic Data Processing
ADP
$107B
$1.01M 0.3%
7,500
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$985K 0.29%
17,800
-23,900
-57% -$1.29M
COST icon
37
Costco
COST
$421B
$982K 0.29%
4,700
LLY icon
38
Eli Lilly
LLY
$1.09T
$956K 0.28%
11,200
KO icon
39
Coca-Cola
KO
$373B
$886K 0.26%
20,200
AAPL icon
40
Apple
AAPL
$4.41T
$852K 0.25%
18,400
DE icon
41
Deere & Co
DE
$167B
$783K 0.23%
+5,600
New +$825K
IFF icon
42
International Flavors & Fragrances
IFF
$21.4B
$744K 0.22%
6,000
NVDA icon
43
NVIDIA
NVDA
$5.43T
$734K 0.22%
124,000
-20,000
-14% -$122K
ZBH icon
44
Zimmer Biomet
ZBH
$18.7B
$635K 0.19%
5,871
GILD icon
45
Gilead Sciences
GILD
$168B
$616K 0.18%
8,700
A icon
46
Agilent Technologies
A
$41.9B
$612K 0.18%
9,900
LOW icon
47
Lowe's Companies
LOW
$121B
-196,290
Closed -$17.2M
MDLZ icon
48
Mondelez International
MDLZ
$79.4B
-421,255
Closed -$17.6M
PM icon
49
Philip Morris
PM
$290B
-131,170
Closed -$13M
PPL
50
PPL Corp
PPL
$26.7B
-512,580
Closed -$14.5M

Similar funds

Stralem & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Stralem & Co held 51 positions worth $339M, down 33% from $503M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Stralem & Co withdrew a net $180M in Q2 2018, closing 5 positions and reducing 30 holdings. Its most notable exit was Starbucks, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Technology and Financials.

Against the trend, Stralem & Co opened a new position in D.R. Horton worth $10.6M.

  • Stralem & Co's largest Q2 2018 buy was D.R. Horton: 259,275 shares worth $10.6M.
  • Stralem & Co added most to Bank of New York Mellon in Q2 2018, an estimated $7.28M increase.
  • Stralem & Co's biggest Q2 2018 reduction was Adobe, cutting an estimated $9.33M.
  • Stralem & Co fully exited Starbucks in Q2 2018, selling an estimated $17.9M.
  • Stralem & Co's ten largest holdings make up 34% of its $339M portfolio in Q2 2018.
  • Stralem & Co opened 5 new positions and closed 5 in Q2 2018.
  • Stralem & Co's portfolio value fell 33% quarter-over-quarter to $339M.

Based on Stralem & Co's 13F filing for Q2 2018, filed 19 Jul 2018.